Restrictions on Avandia were put in place in 2009 . Because there were multiple conflicting signals of cardiovascular risk associated with the drug , Woodcock recommended that Glaxo commission an outside independent group to review RECORD 's results . Studies show an increased risk of serious heart problems . Additional research shows no additional cardiovascular risks with Avandia .
Restrictions on Avandia were put in place in 2009 . Studies show an increased risk of serious heart problems . Additional research shows no additional cardiovascular risks with Avandia .